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Definitions 
Actively Infected premises:  Premises where a presumptive FMD positive case or confirmed 
positive case exists based on laboratory results, compatible clinical signs, case definition, and 
international standards. 
Aerosol transmission:  The introduction of airborne droplet nuclei or small particles in the 
respirable size range containing infectious agents into the air. 
At-risk premises:  Premises with susceptible animals that have not developed clinical signs 
compatible with FMD. 
Backgrounding or Stocker Operation:  A stage of cattle production when calves eat roughage 
and/or light energy rations or graze pasture (native grass or winter wheat), which encourages 
structural growth.  During the backgrounding period, producers decide when to place them in 
feedlots to fatten for slaughter. 
Beef replacement heifer:  A young female bovine that is raised for the purpose of replacing and 
improving the cow herd. 
Carrier cattle:  Cattle that have recovered from clinical disease and have at least one of multiple 
positive oesophageal-pharyngeal samples 28 days post infection with FMDv (as defined by OIE).   
Clinically-infected/Clinically infectious phase (Ic):  Animal is viremic, shedding virus and is 
exhibiting clinical signs of disease.  
Confirmed positive case (of FMD):  An animal with clinical signs consistent with FMD and from 
which FMDv is isolated and identified in a USDA laboratory or other laboratory designated by 
the Secretary of Agriculture. 
Control Area:  Consists of an infected zone and a buffer zone.  Initially, the entire State, 
Commonwealth, Tribal Nation, or territory may be declared a control area and subject to 
movement restrictions until appropriate surveillance and epidemiological evidence has been 
evaluated and the extent of the outbreak known. 
Cow-Calf Operation:  An operation that breeds and maintains cows for the primary purpose of 
producing calves to enter the beef production system. 
Cross-contamination:  The transfer of harmful bacteria, viruses or other microorganisms from 
an infectious animal or site to a susceptible animal or site either directly, or indirectly via a 
fomite. 
Environmental Contamination:  The introduction of infectious organisms into water or soil 
from excretions or secretions of infected animals. 
Environmental Fomites:  Dirt, dust, bedding, manure, and urine particles that are capable of 
carrying infectious organisms and transfer them to susceptible animals. 
Excretions:  Waste matter that has been expelled from animals (i.e. manure, urine, sweat) 
Feedlot (feedyard):  An operation or facility (premises) where cattle are fed in a confinement 
setting primarily for the purpose of harvesting for beef production.  Cattle are kept in 
groups/pens and fed custom diets that are designed for efficient weight gain.  Cattle enter 
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feedlots as weaned calves from cow-calf operations, stocker or yearling cattle that have been 
backgrounded at stocker operations and may range in weight from 350 – 1000 lbs. Cattle leave 
the feedlot when they have reached target market weights ranging from 1200 – 1600 lbs.  
Feeder cattle:  Calves primarily from cow-calf operations that are marketed to be placed into a 
feedlot to be fed primarily for the production of beef.   
Fomites:  Inanimate objects (i.e. equipment, vehicle) that, when contaminated with a viable 
disease agent, can serve as a source of infection for a susceptible host (i.e. equipment, vehicle). 
Free Country or Zone:  OIE defines a country or zone to be FMD-free by stamping out without 
vaccination after minimum of 3 months.  If a country or zone uses vaccination, this waiting 
period becomes 6 months.  If the “vaccination-to-live plan” is used without stamping out, these 
waiting periods become 1 year and 2 years, respectively.  This definition is based on the 
assumption that “free” means no infectious animals are present. 
Hazardous Material:  A substance or material that the Secretary of Transportation has 
determined is capable of posing an unreasonable risk to health, safety, and property when 
transported in commerce in a particular amount and form, and has been designated as 
hazardous under section 5103 of federal hazardous materials transportation law (49 U.S.C. 
5103).  The term includes hazardous substances, hazardous wastes, marine pollutants, elevated 
temperature materials, materials designated as hazardous in the Hazardous Materials Table of 
49 CFR 172.101, materials that meet the defining criteria for hazard classes and divisions in part 
173 of subchapter C of chapter I. 
Herd:  The population of animals at defined premises. 
ID50:  Infectious Dose 50; amount of pathogen measured as number of colony forming units 
(CFU) for bacteria or number of virus particles required to infect 50% of exposed individuals. 
Incubation Period:  The known or assumed period between the introduction of a pathogen into 
a susceptible animal and the occurrence of the first clinical signs of the disease. 
Infected:  Includes all phases of disease (L + Ip + Ic):  latent (L), pre-clinically infected (Ip) and 
clinically infected (Ic). 
Latent phase (L):  Susceptible animal has been exposed and is incubating the virus, but is not 
viremic.  
Mechanical Transmission:  The passive transfer of harmful agents of disease, either indirectly 
via fomites or directly via vectors. 
Non-carrier cattle:  Cattle that have recovered from clinical disease, no longer harbor FMDv 
and, therefore, are no longer infectious. 
Operations:  Farm, ranch, feedlot, or other organized unit of production. 
Pre-clinically infected phase/Pre-clinically infectious:  Animal is viremic, is shedding virus, but 
has not yet developed clinical signs.  Pre-clinical animals also fall into the viremic non-clinical 
group. 
Premises:  Locations where livestock are raised, housed, or pass through during commerce. 
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Pre-viremia:  The period from which an animal is first infected with FMDv until virus is first 
detected within circulating blood with a sustained and increasing trend.  This period includes 
the latent phase (Arzt, Juleff, Zhang, & Rodriguez, 2011). 
Post-viremia:  The period following viremia and it begins with the first negative blood assay.  
This period includes: resolution of clinical signs, persistent infection, and chronic phase (Arzt et 
al., 2011). 
Probang (oesophageal-pharyngeal) samples:  These samples are collected by inserting a 
probang (a slender rod with a sponge or ball at the end) over the tongue and moving it 
vigorously back and forth between the first part of the esophagus and the back of the pharynx. 
Recovered phase (R):  Previously infected animal where at least 28 days have passed since the 
last observable clinical signs (OIE). 
Recovered premise:  A premise previously infected with FMD where at least 28 days have 
passed since the last observable clinical signs. This definition is based on the assumption that all 
cattle on the premise have recovered from clinical disease, resulting in a population that 
contains only recovered cattle that are either carriers or non-carriers.  This definition is in 
contrast to the OIE definition of a Free Country or Zone (see above for definition). 
Secretions:  Substances that are released from a gland or cell (i.e. nasal fluids, respiratory fluids, 
ocular fluids). 
Shedding phase:  Time interval between the time an animal begins shedding virus to the time 
an animal is no longer shedding virus and it includes the pre-clinical, and clinical infectious 
phases.   
Slaughter/Harvest establishment:  Premises that receive cattle for slaughter that may be 
located within or outside of the control area. 
Stamping out:  Depopulation of clinically affected and all presumed exposed susceptible 
animals located on a premise. 
Sub-clinical animals:  Infection of animals with FMDv where that event is never followed by 
observable signs of clinical disease.  Animals are considered to be infectious and represent a 
risk for spread of the virus because they can go undetected.  Sub-clinical animals also fall into 
the viremic non-clinical group. 
Susceptible:  Healthy animal species that have the potential to become infected with FMDv. 
TCID50:  Tissue Culture Infective Dose 50; the amount of a pathogen measured as number of 
virus particles required to produce pathological change in 50% of cell cultures inoculated, 
expressed as TCID50/ml. 
Vector:  An organism that does not cause disease, but spreads infection by moving the 
pathogens between hosts. 
Viremia:  FMDv is circulating in the blood stream and there is evidence of active viral 
replication.  Susceptible species can be viremic and shedding virus before they develop clinical 
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signs.  Includes the pre-clinical (I) and clinical (C) phases of the disease in this pathway analysis.  
Onset of viremia has been found to occur 16-72 hours post-inoculation (Arzt et al., 2011). 
Viremic non-clinical animals:  Animals that are not showing clinical signs but are shedding the 
virus.  This group includes animals that are both pre-clinical and sub-clinical. 
Weaned calf crop:  The number of calves birthed on a cow-calf operation that go on to be 
weaned.   
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Executive Summary 
The present document proactively evaluated the FMDv transmission pathways associated with 
the movement of beef cattle not showing Foot and Mouth Disease (FMD) clinical signs from 
recovered or infected feedlot premises to offsite harvest facilities during a FMD outbreak.  The 
analysis evaluated the most up to date available science and solicited opinion from experts 
when data was lacking.  This analysis was proactive in nature and the scenarios, pathways and 
conveyance types assessed were based on the current practices and regulations applicable 
during a FMD outbreak in the United States (US).  Modeling was used to estimate the number 
of latent, pre-clinical, clinical, and recovered animals during the course of infection at various 
time intervals.  The main outcomes of the analysis should be reviewed if needed as new data 
becomes available in the future. 
 
Main results: 
“Stamping out” FMDv infected premises has, historically, been the method of choice in the 
control of FMDv outbreaks.  The purpose of this pathway analysis was to provide insight into 
the potential pathways for viral spread associated with alternative solutions to stamping out in 
the event of a catastrophic FMDv outbreak in the U.S. 
 
Modeling results are based on the assumption that FMD detection would occur when 10% of a 
10,000 head herd is showing clinical signs, which was predicted to occur at approximately 17.5 
days (95% Confidence Interval:  17.4-17.7) post-infection.  At this time, the percentage of 
viremic pre-clinical and clinical animals that are actively shedding virus would be approximately 
11% (1,095/10,000) and 7% (692/10,000), respectively.  If a decision is made to move animals 
not showing clinical signs at this point, a significant proportion of pre-clinical animals will be 
part of the group moving to harvest. 
 
The pathway analysis identified the following variables associated with the likelihood of disease 
transmission during the movement of cattle from infected or recovered feedlot premises: 
 
Mechanism of spread: 
Samples taken from infected animals that had the highest FMDv concentration were nasal 
discharge (6.09 log TCID50/mL), upper respiratory tract (5.70 log TCID50/mL), skin (7.4 log 
TCID50/mL), and probang samples (4.91 log TCID50/mL).  Airborne excretion (4.33 log TCID50/mL) 
of virus also represents route of virus transmission.  The bodily secretions/excretions with the 
lowest FMDv amount were urine (1.93 log TCID50/mL) and manure (1.55 log TCID50/mL).  While 
urine and manure were shown to carry the least amount of virus, these excretions are likely to 
be present in significantly higher amounts in the environment and, consequently, on the 
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animals and within the truck during transport.  It is, therefore, important to consider how the 
amount of each secretion/excretion could contribute to disease spread. 
 
Disease phase: 
Transmission more likely:  Viremic non-clinical (pre-clinical and sub-clinical) animals are more 
likely to transmit disease.  Model results showed a waiting period of 25 days post-detection 
(assuming detection occurred on day 17 post-infection) would reduce the proportion of viremic 
pre-clinical animals to almost 0 (1.2/10,000) and actively shedding animals to 1.9% 
(189/10,000).  In this scenario, most of the animals would be recovered from clinical infection. 
 
Transmission less likely:  Non-viremic, non-clinical (latent or recovered) animals are less likely to 
transmit disease.  While virus has been found to be present in animals during these phases, 
there has been no evidence of transmission.   
 
Time of movement: 
Transmission more likely:  Disease transmission is more likely to occur when high numbers of 
viremic animals are present.  This would result in increased shedding during transport and 
increased virus in the farm environment.  Model results showed the highest number of viremic 
pre-clinical and clinical animals to be present around 11 days post-detection (assuming 
detection occurred on day 17 post-infection), with proportions of  5.1% (512/10,000) and 
28.5%(2,851/10,000), respectively.   
 
Transmission less likely: Disease transmission is less likely to occur when low numbers of 
viremic animals are present.  Model results showed a waiting period of 48 days post-detection 
would result in the lowest number possible of pre-viremic and clinical animals at 0.00002% 
(0.002/10,000) and 0.009%(0.94/10,000), respectively.  At this point, approximately 96% 
(9,628/10,000) of the herd is recovered from clinical infection and, therefore, less likely to 
transmit the disease. 
 
Vaccination status: 
Transmission more likely: The group that is more likely to transmit disease would be those 
animals that are not vaccinated since vaccination has been shown to greatly reduce the amount 
of viral shedding and clinical signs. 
   
Transmission less likely:  The group that is less likely to transmit disease would be those animals 
that are vaccinated.  The efficacy of the vaccine would be partially dependent on the time that 
has elapsed between immunization and disease exposure as vaccines have been shown to be 
more effective when time is allowed for the animal to develop immunity prior to exposure. 
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The document identified several data gaps and further research is recommended to better 
estimate the risk of disease spread associated with each pathway and to be able to provide 
recommendations for the movement of cattle in these scenarios. 
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Background 
This pathway analysis was performed by the University of Minnesota’s Center for Animal Health 
and Food Safety to proactively evaluate different scenarios for moving beef cattle from a FMD-
infected or FMD-recovered feedlot premises during a FMD outbreak in the US to slaughter, as it 
relates to potential spread to susceptible livestock.   
 
FMD is a highly contagious viral disease of cattle and other cloven-hoofed animals such as 
swine, sheep, and goats.  Thus, there is great potential for this virus to cause severe economic 
loss when animals become affected.  Infection with the virus is characterized by fever and 
blister-like sores on the feet, tongue, lips, inside the mouth and in females on the teats, 
resulting in weakened animals and, ultimately, reduced production. 
 
In the event of a FMD outbreak in the US, Local, State and Federal authorities will implement a 
foreign animal disease emergency response as described in the United States Department of 
Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) Framework for Foreign 
Animal Disease Preparedness and Response Plan (USDA APHIS, 2014).  This response includes 
control and eradication strategies that will utilize depopulation, quarantine, vaccination, and 
movement control measures to stop the virus spread and eliminate it from affected and 
susceptible populations.  For the purpose of this analysis, knowledge of how authorities will 
respond to a catastrophic FMD outbreak will be as follows:  
 
● Transition to a long-term eradication program, including Emergency Vaccination to Live 
without Stamping-Out:  Vaccination of susceptible animals without depopulation of 
infected animals or subsequent depopulation of slaughter or vaccinated animals (USDA 
APHIS, 2014).  This strategy involves the following: 
- A protective emergency vaccination strategy 
- Requires the establishment of one or more Vaccination Zones (VZ) free of FMD, 
the establishment of one or more Control Areas (CA) for infected animals, and 
movement controls to keep infected animals out of VZs free of FMD. 
- DIVA (Differentiating Infected from Vaccinated Animals) testing may be 
necessary for movement between zones, interstate commerce, and international 
trade. 
- Vaccinated animal identification, movement controls, traceability, and an 
effective, scalable permitting system may be necessary. 
● Transition to allowing movement of vaccinated animals (14 days post-vaccination) from 
premises with no current clinical evidence of infection with Foot and Mouth Disease 
virus (FMDv). 
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● Consideration will be given to allowing movement of non-infected animals (including 
vaccinated animals) according to the Secure Food Supply Plans.  Animals must meet 
vaccination withdrawal period (if it applies) and be able to pass Food Safety Inspection 
Service (FSIS) ante-mortem inspection to be slaughtered. 
 
A pathway analysis in the animal health context comprises a framework that identifies the 
potential routes of spread of a pathogen or virus in a country, region or farm using available 
scientific information.  Completing this type of analysis in a timely manner during an outbreak is 
typically impractical.  Analyses conducted proactively, before an outbreak occurs, provide the 
framework necessary for decision makers to identify and better understand the different risks 
associated with the movement of live animals.  This pathway analysis is a component of a full 
risk assessment and the risk assessment process will more fully evaluate the risks that were 
identified in the different pathways. 
 
The literature and expert opinions used to guide this document were based primarily on 
experimental work in which a limited number of animals and specific virus strains were 
analyzed.  This document should not be used to predict the spread of disease in an outbreak as 
actual virus behavior in an outbreak could vary significantly depending on the circumstances.    
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Scope 
The purpose of this document is to provide a pathway analysis for the movement of beef cattle 
not showing FMD clinical signs from FMD-infected and FMD-recovered feedlots to slaughter 
within or outside of the control zone in the event of a FMD outbreak in the U.S.  The analysis is 
based on the potential presence of infectious FMDv in the live cattle or on fomites at the time 
of transportation and the potential release of the virus with the movement of live cattle to 
slaughter.  The analysis discusses the opportunities that:  1) Vaccinated and unvaccinated cattle 
with potential for spreading the virus (latent, viremic non-clinical, or carrier) could be moved 
from the infected/recovered premises to the harvest site; 2) Infectious FMDv could be present 
in the animals moved to slaughter and/or on fomites and released into the environment during 
transportation.   
 
A 42 day post-detection waiting period was chosen in two of the scenarios based on an 
estimate of the total time it would take for an individual animal to enter the recovered phase.  
This number was established based on knowledge of the following: 
- A clinically infectious phase that lasts up to 14 days. 
- The OIE definition of recovered which states, “a previously infected animal where at 
least 28 days have passed since the last observable clinical signs”. 
The sum of these two numbers means that 42 days after detection, you can assume an infected 
animal has most likely entered the recovered phase. 
 
This analysis utilizes five possible scenarios to represent potential situations at the time of 
transportation of live cattle from a feedlot (assuming all animals to be moved are free from 
clinical signs of FMD): 
 
1. The disease is allowed to progress through an infected herd and at least 42 days have 
passed since the first observable clinical signs in the herd prior to movement of eligible 
cattle (at or near target weights) to harvest. 
2. The feedlot is actively infected (animals with clinical signs are present) and cattle not 
showing clinical signs of FMD (non-infected, latent, viremic non-clinical, recovered) that 
are eligible for harvest (at or near target weights) are moved to harvest. 
3. Upon detection, all cattle in the infected feedlot are vaccinated, at least 42 days have 
passed since the first observable clinical signs and cattle eligible for harvest (at or near 
target weights) are subsequently moved to harvest.  
4. Upon detection, all cattle in the infected feedlot are vaccinated, at least 14 days have 
passed as the waiting period and cattle not showing clinical signs of FMD (non-infected, 
latent, viremic non-clinical, recovered) that are eligible for harvest (at or near target 
weights) are moved to harvest. 
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5. The feedlot is not known to be infected (infected but undetected or negative) and 
located within a control zone.  All animals have been vaccinated and cattle eligible for 
harvest (at or near target weights) are moved to harvest after the 14 day waiting period. 
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Assumptions 
This pathway analysis takes into consideration all applicable regulations, including preventive 
measures already in place, as well as additional preventive measures that will likely be 
implemented during an outbreak based on current USDA policy.  This analysis is proactive in 
nature and cannot address the specific circumstances surrounding an outbreak in detail.  
Therefore, some assumptions were made to establish context and applicability.  These 
assumptions are: 
 
- There is an ongoing FMD outbreak in the U.S. 
- Response is following the USDA FMD response plan, quarantine and movement control. 
- The FMD outbreak is at a scale (Type 4:  Widespread or National FMD Outbreak or Type 
5:  Catastrophic FMD Outbreak) that has become endemic and strategies besides 
depopulation, proposed by the FAD PReP Strategy Document, vaccinate-to-live and 
vaccinate-to-slaughter, are being considered.  
- The outbreak is caused by a single type of FMDv. 
- Animals showing clinical signs will not be moved from the premise. 
- The infected premise is a large scale feedlot (> 10,000 head). 
- Biosecurity measures were implemented at affected farms and followed the National 
Animal Health Emergency Management System (NAHEMS) Guidelines. 
- All transport methods/vehicles will be cleaned and disinfected after each load and 
unload of cattle following FAD PRep guidelines. 
- The analysis will consider the pathways associated with the movement of cattle from 
feedlot premises to harvest only; movements to other types of facilities are not 
considered.   
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Hazard identification 
Background 
FMD is a highly contagious viral disease affecting primarily cloven-hoofed animals.  The disease 
is characterized by the development of vesicles in and around the mouth and on the feet.  
Although natural FMD infection rarely causes death of mature animals, the disease results in 
decreases in livestock productivity and causes serious economic impacts on international trade 
of animals and animal products (OIE, 2013). 
 
FMD was last reported in the U.S. in 1929 and in North America in 1952 (Canada) and 1954 
(Mexico).  As of November 2015, of the OIE’s 180 Member Countries, 67 are recognizes as free 
without vaccination.  The OIE recognizes 1 country as free with vaccination and 16 have official 
free zones (12 without vaccination, 8 with vaccination).  The United States recognizes 3 
countries that have FMD-free zones without vaccination and does not recognize zones or 
countries as FMD-free with vaccination (USDA APHIS, 2015).  The potential risks and impacts 
that FMD may pose were demonstrated by the severe economic and livestock losses 
experienced in the United Kingdom in 2001 and the consequences of these FMD outbreaks 
have reinforced the need for FMD awareness and evaluation of the possible pathways by which 
FMDv can spread. 
 
Virus Characteristics 
There are seven FMDv serotypes:  A, O, C, SAT (South African Territories) 1, 2, 3, and Asia 1.  
Each serotype can be divided further into subtypes.  Within each serotype is a spectrum of 
antigenic variation, resulting in strains having close or distant relationships to each other.  All 
serotypes produce disease that is clinically indistinguishable, but immunologically distinct.  No 
cross-immunity is conferred between serotypes.  Serotype O is the most common serotype 
isolated from the field and occurs in many parts of the world and serotype A is considered to 
have the greatest antigenic variation (Alexandersen & Mowat, 2005; Jamal & Belsham, 2013; 
Kitching, Knowles, Samuel, & Donaldson, 1989; Knowles & Samuel, 2003). 
 
Host range of FMD 
Cloven-hoofed animals (ungulates) are the natural domestic and wild hosts of FMDv.  They are 
susceptible to all 7 serotypes and many of the subtypes of FMDv.  The severity of illness may 
differ depending on the specific serotype and the species that is affected.  Susceptible species 
include, cattle, pigs, sheep, goats, water buffalo, impala, bison, African buffalo, American bison, 
antelope, reindeer, moose, elk (although low), hedgehogs, porcupines, giraffes, elephants and 
Bactrian camels.  Water buffalo and African buffalo are of particular importance because of 
their ability to act as carriers and maintain the virus for long periods of time.  Horses are 
resistant to FMD infection and New World camelids (llamas, alpacas, vicunas and guanacos) 
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have low susceptibility to FMD infection.  FMDv may also be transmitted to mice, rats, guinea-
pigs, rabbits, hamsters, embryonating chicken eggs, chickens, and various wild species, 
including European hedgehogs, chinchillas, muskrats, armadillos and peccaries.  However, these 
latter species are not generally capable of spreading FMD (Alexandersen & Mowat, 2005). 
 
Humans can become infected with FMD through (1) handling of diseased livestock with virus 
entry through skin wounds and mucous membranes, (2) exposure through laboratory 
situations, or (3) by drinking infected raw milk.  The virus is not readily transmissible to humans 
and thus, should not be considered a zoonotic disease.  Cases of human disease are rare and 
have resulted in temporary and mild signs of disease (fever, vesicles on the hands, feet or in the 
mouth) (Alexandersen & Mowat, 2005). 
 
Environmental Persistence 
FMDv retains infectivity for considerable periods of time in the environment, provided it is 
protected from desiccation, heat and adverse pH conditions.  Various studies suggest FMDv 
remains viable for a wide range of times based on fomites and environmental conditions (The 
Center for Food Security and Public Health - Iowa State University, 2014).  The virus may survive 
for 14 days in dry fecal material; six months in slurry in winter; 39 days in urine; 28 days on the 
surface of soil in autumn; and three days on the surface of soil in summer.  Such observations 
have generally been made in countries with a temperate climate, and these survival times can 
be expected to be similar in hotter climates (Geering WA., 2002).  In the lab, FMDv has been 
shown to survive more than 3 months on bran and hay, about 2 months on wool at 4°C, and 2 
to 3 months in bovine feces (The Center for Food Security and Public Health - Iowa State 
University, 2014).  FMDv is sensitive to desiccation.  Relative humidity and temperature are the 
primary factors that affect survival of the virus in the environment.  The virus survives best 
when the relative humidity exceeds 70%, and has poor survival when the relative humidity is 
below 50-60% (Sellers, 1971) but this can vary depending on the FMDv strain that is circulating.  
Virus stability increases at lower temperatures and has been shown to remain viable for up to 
one year at 4°C in cell culture medium (The Center for Food Security and Public Health - Iowa 
State University, 2014).  FMDv is inactivated when the pH is below 6.0 or above 9.0 (OIE, 2013; 
The Center for Food Security and Public Health - Iowa State University, 2014).  Sunlight and 
ultraviolet radiation have little effect on virus persistence (Donaldson & Ferris, 1975).  These 
data support the potential risk for disease transmission to susceptible species due to the FMDv 
survival in truck surfaces and fecal material during the movement of infected animals to the 
harvest facility.   
 
Transmission 
Mechanism of Spread: 
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FMDv is highly contagious, and can be transmitted by a variety of mechanisms.  The most 
common mechanism of spread of FMDv is by direct animal contact, which can occur by the 
airborne transfer of droplets or by mechanical transfer through cuts or abrasions in the skin or 
mucous membranes.  Other common mechanisms by which FMDv is spread are summarized 
below (Alexandersen, Zhang, Donaldson, & Garland, 2003; Alexandersen & Mowat, 2005; 
Gloster et al., 2010). 
● Indirect mechanical transfer through susceptible animal contact with virus on the 
surfaces of fomites (hands, footwear, clothing, vehicles, and equipment) and 
subsequent virus entry through cuts or abrasions in the skin or mucosa. 
● Ingestion of FMDv contaminated feed or contact with contaminated animal products 
(milk, meat, semen). 
● Spread by wind, which requires the simultaneous occurrence of particular 
epidemiological and climatic conditions.  This type of spread will have a more significant 
effect on cattle and other ruminants as they have been shown to be more sensitive to 
infection by the airborne route. 
 
Virus Infectivity in Cattle: 
Cattle have been shown to require as little as 10 to 25 TCID50 (tissue culture infective dose) of 
virus to establish infection via the respiratory route (Donaldson, Gibson, Oliver, Hamblin, & 
Kitching, 1987; Kitching, Hutber, & Thrusfield, 2005; Thurmond & Perez, 2006) due to their 
large respiratory volume.  Cattle require a higher dose via the oral route and this has been 
shown to be 105 to 106 TCID50 (Alexandersen et al., 2003; Sellers, 1971).  Nasal instillation also 
requires a much larger volume than the respiratory route at 104 to 105 TCID50 (Alexandersen et 
al., 2003; McVicar & Sutmoller, 1976).  The dose to establish infection via damaged skin 
required as low as 100 TCID50, although more consistent results were observed closer to a dose 
of 104 to 105 TCID50 (Alexandersen et al., 2003; Sellers, 1971).  The data is displayed in Table 1.  
These doses represent estimates based on experiments of small groups of animals and they 
may not be applicable to a large herd. 
 
Table 1:  Estimated minimum FMDv doses for infection in cattle (Alexandersen et al., 2003) 
 Inhalation Intradermal Intramuscular Nasal 
Instillation 
Oral Units 
Cattle 10 100 104 104 – 105 105 - 106 TCID50 
 
Incubation Period 
The incubation period of an infectious disease is the time interval between exposure to an 
infective dose and development of clinical signs and it includes both the latent and pre-clinical 
infection phases.  The incubation period for FMD is known to be variable and dependent on the 
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strain and dose of the virus, the route of transmission, the husbandry situation, and the species 
(Alexandersen et al., 2003; Alexandersen, Kitching, Mansley, & Donaldson, 2003; Alexandersen, 
Quan, Murphy, Knight, & Zhang, 2003; Alexandersen & Mowat, 2005).  It is well-known that 
FMD infected animals can shed virus during the pre-clinical infectious phase of the incubation 
period, before the first detectable clinical signs are noted (Mardones, Perez, Sanchez, Alkhamis, 
& Carpenter, 2010; Orsel, Bouma, Dekker, Stegeman, & de Jong, 2009) (Figure 1).   
 
While the incubation period has been shown to range from 2 to 14 days in cattle, the OIE uses 
the full 14 days as the incubation period of FMD for control purposes.  This variation in time is 
the result of the following (Alexandersen et al., 2003; OIE, 2013): 
● A strong relationship between dose and length of incubation. The higher the dose, the 
shorter the incubation period. 
● This concept also holds true for amount of contact between animals.  The more contact 
infected animals have with one another, the shorter the incubation period. 
● Stocking density, herd management, housing, ventilation and handling all play a role in 
how quickly the virus will spread through the infected herd. 
 
Disease Phases 
The shedding phase of an infectious disease is the time interval between the time an animal 
begins shedding virus to the time an animal is no longer shedding virus and it includes the pre-
clinical, and clinical infectious phases (Figure 1).  The carrier phase includes animals that have 
recovered from clinical disease and have at least one positive oesophageal-pharyngeal sample 
28 days post infection with FMDv. 
 
 
Figure 1: FMDv infection timeline by phase 
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Latent Phase:  During this phase, virus is not detectable in the blood and animals are generally 
not considered to be infectious.  The mean length of time this phase was shown to last in beef 
and dairy cows was between 2 to 3.7 days (Backer, Hagenaars, Nodelijk, & van Roermund, 
2012; Bates, Thurmond, & Carpenter, 2003; Carpenter, Thurmond, & Bates, 2004; Mardones et 
al., 2010). 
 
Pre-clinical phase:  In this phase, the animal is viremic, is shedding virus, but has not yet 
developed clinical signs.  Studies have shown this phase to last from 1.95 to 2.6 days (Bates et 
al., 2003; Carpenter et al., 2004; Mardones et al., 2010; Orsel et al., 2009).  The onset of viremia 
has been shown to occur at or near the peak of FMDv detection from OP samples and that is at 
16 to 72 hours (up to 3 days) post-inoculation (Arzt et al., 2011; McVicar & Sutmoller, 1976).  
While viremia typically coincides with the clinical phase of the disease, it can be readily 
detectable 1 to 2 days prior to the development of clinical signs (Alexandersen, Zhang, Reid, 
Hutchings, & Donaldson, 2002; Alexandersen et al., 2003; Arzt et al., 2011).  Once the animal 
becomes viremic, all excretions and secretions can contain virus (Alexandersen et al., 2003; Arzt 
et al., 2011).  There is a higher likelihood of transmission from this group because of their ability 
to shed virus for 1-2 days prior to showing any clinical signs of disease. 
 
The presence of infectious virus in the oropharyngeal area can be detected as early as 2 to 14 
hours after intranasal deposition (depending on viral strain and dose administration) which is 
well before clinical signs may appear (Arzt et al., 2011; McVicar & Sutmoller, 1976).  However, 
the presence of infectious virus does not always mean transmission will occur as enough virus 
must be present in order for it to cause disease. 
 
Sub-clinical phase:  Orsel et al., 2009 described sub-clinically infected animals as those who 
shed virus without ever developing clinical signs (Orsel et al., 2009).  This is in contrast to pre-
clinical animals, in which a proportion of the animals that are shedding without showing clinical 
signs go on to develop clinical disease (Blanco, Romero, El Harrach, & Sanchez-Vizcaino, 2002).  
Studies have shown that a high proportion (11%) of susceptible cattle that were exposed by 
contact to a variety of strains did not develop clinical signs of FMD while they were shedding 
virus (Sutmoller & Casas, 2002).  These animals represent a higher likelihood of disease spread 
because they may be shedding virus and go undetected (Sutmoller & Casas, 2002). 
 
Clinical phase:  In this phase, the animal is viremic, shedding virus and is exhibiting clinical signs 
of disease. Spread from the initial sites of primary replication results in infection of the lymph 
nodes and the bloodstream, and resultant viremia distributes the virus to all organs and tissues.  
Further replication of virus occurs particularly at sites where characteristic lesions of FMD 
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develop (Alexandersen et al., 2003; Burrows, Mann, Garland, Greig, & Goodridge, 1981; Dillon, 
2011).  Clinical signs typically begin around 3-4 days post-infection (Chase-Topping et al., 2013).  
The peak period of shedding has been shown to occur 2 to 7 days post-infection (Parthiban, 
Mahapatra, Gubbins, & Parida, 2015) and may coincide with the appearance of clinical signs 
(McVicar & Sutmoller, 1976).  Cox et al., 2005 showed the highest average levels of detectable 
viral RNA to be between 4 and 10 days post-challenge exposure (Cox et al., 2005).  FMDv is 
known to have a direct effect on the skin and that it acts as a major viral replication site.  While 
the virus is known to be present when vesicles are observed, it can also be present prior to 
viremia and when the skin appears normal (Alexandersen et al., 2003; Brown,C.C.1992; Dillon, 
2011). 
 
Recovered cattle (non-carriers and carriers):  This term refers to cattle that have recovered from 
clinical disease and include animals in the carrier and non-carrier stage:   
a) Non-carrier cattle are no longer carrying the virus and are considered to be non-
infectious and fully recovered from FMDv. 
b) Carrier cattle are defined as having at least one of multiple positive oesophageal-
pharyngeal samples 28 days post infection with FMDv (as defined by OIE).   
 
It has been shown that over 50% of cattle can become carriers with this proportion ranging 
from 3.34% up to 80%. (Alexandersen, Zhang, & Donaldson, 2002; Cox et al., 2005; Kitching et 
al., 2005; Salt, Samuel, & Kitching, 1996; Sutmoller & Casas, 2002).  Cattle that become carriers  
may have recovered from clinical disease or had been vaccinated and exposed (Arzt et al., 
2011).  All 7 FMDv types are capable of inducing persistent infection lasting up to 42 months 
(Thomson, 1996).  Alexandersen et al., 2002 hypothesizes that persistence is the result of 
multiple factors including; a specialized target epithelial cell population in the pharynx, and 
specific cellular responses (Alexandersen et al., 2002).  It appears that FMDv appears to persist 
primarily in the throat (oropharyngeal) region of carrier cattle (Parthiban ABR., et al., 2015; 
Stenfeldt and Belsham, 2012; Pacheco J., et al., 2015).   
 
The rate of FMDv transmission from carriers to susceptible animals was shown to be negligible 
over the course of the 75 days that the animals were observed in a recent study performed by 
Parthiban, et al., 2015 and it was, therefore, determined that the probability of FMDv 
transmission from carriers would be very low (Parthiban et al., 2015).  There is currently no 
research or outbreak data proving the capability of carrier cattle to infect other susceptible 
species.   
 
FMDv concentration in cattle secretions 
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Viremic non-clinical -VS- clinical cattle:  A review of reported maximum virus titers in various 
excretions and secretions of FMDv infected cattle are displayed in Table 2 and it is important to 
recognize that these values can vary based on serotype and strain of FMDv.  The highest FMDv 
median amounts in cattle were shown to reside in the upper respiratory tract secretions and 
excretions of cattle (Bravo de Rueda, Dekker, Eble, & de Jong, 2014).  Rueda et al, 2014 also 
developed a model to predict the amount of virus present in various secretions during the 
clinical and viremic non-clinical phases (pre-clinical and sub-clinical cattle).  The amount of virus 
was estimated to be lower in all secretions and excretions of viremic non-clinical cattle, except 
milk when compared to the clinical phase (Bravo de Rueda et al., 2014).  While the amount of 
virus in the body fluids of viremic non-clinical cattle appear to be less, it is still known that 
disease can occur in this group of animals (Orsel et al., 2009). 
 
Tables 2 compares the amount of FMDv found to be shed by cattle in studies with predictions 
of the amount of FMDv shed by clinical and viremic non-clinical cattle.  The secretions and 
excretions that tend to contain the most virus, whether in clinical or viremic non-clinical cattle 
are as follows:  Probang, upper respiratory tract, blood, and milk.  The amount of virus excreted 
in these various bodily fluids as well as the amount of each bodily fluid excreted/secreted by 
the animals is important in determining how much virus may be transported if infected, 
undetected animals are moved off a premise.   
 
Table 2:  FMDv virus excretion of cattle (1Bravo de Rueda, et al., 2014; 2Dillon, 2011) 
 1Maximum virus titer average (range) 
2Average virus concentration 
1Model Results 
Disease phase 
(combined virus excretions) 
Clinical:  14.62 (1.00,8.50) log TCID50/mL 
Viremic non-clinical:  14.52 (0.95,8.65) 
log TCID50/ml 
Clinical 
(log TCID50/mL) 
Viremic non-
clinical 
 (log TCID50/mL) 
Blood 14.03 (0.95,6.20) log TCID50/mL 4.55 3.58 
Feces 11.55 (1.50,1.75) log TCID50/mL 1.92 1.22 
Milk 14.48 (2.15,7.35) log TCID50/mL 3.97 5.8 
Nasal Discharge only 16.09 (2.75,7.85) log TCID50/mL NA NA 
Probang 14.91 (2.20,8.65) log TCID50/mL 6.71 6.07 
aAirborne excretion 14.33 (3.88,5.08) log TCID50/mL NA NA 
Semen 14.55 (2.10,6.20) log TCID50/mL 3.24 NA 
26 
 
Upper Respiratory Tract 
(OPF swabs, saliva and 
nasal discharge) 
15.70 (1.25,8.50) log TCID50/mL 5.27 2.76 
Urine 11.93 (1.00,3.80) log TCID50/mL 2.31 NA 
Skin Clinical:  27.4 log TCID50/g 
Viremic non-clinical:  25.1 log TCID50/g 
NA NA 
*TCID50 = the infective dose which will infect 50% of cultures. 
*Maximum virus titer average = the average of maximum titers over time from individual animals 
*NA = Not available 
aTCID50 per animal per day for airborne excretion 
 
Table 3 summarizes the amount of FMDv that may be shed in secretions from cattle during the 
acute phase of the infection.  These animals were followed to see if they became carriers or 
non-carriers following the acute phase of infection which allowed for retrospective analysis of 
viral shedding.  Following clinical infection, approximately 50% of the animals will fully recover, 
meaning no virus will be present, and 50% of the animals will continue to harbor virus 
intermittently in the oropharyngeal region for up to 3.5 years as carriers.  Parthiban et al., 2015 
discusses the amount of virus shedding that will occur in clinical animals during the acute phase 
of the infection.  Cattle that eventually become non-carriers were shown to shed less virus in 
both nasal fluid and saliva than cattle that became carriers.  Results showed that there was 
variability in the amount of virus shed by animals in the acute phase of the infection and this 
variability is important in determining the amount of virus shedding that may be expected in an 
affected herd. 
 
Table 3:  FMDv concentration in the excretions/secretions of cattle during the acute phase of 
infection (Parthiban, et al., 2015) 
  Carriers  Non-carriers  Units 
Peak 
Shedding 
Nasal Fluid 106.0 105.5 log10 copy number/mL 
Saliva 106.9 106.5 log10 copy number/mL 
Total 
Shedding 
Nasal Fluid 106.6 106.0 log10 area under the curve 
(copies/mL) 
Saliva 107.4 107.0 log10 area under the curve 
(copies/mL) 
 *Copy number/mL = the number of RNA copies of virus that are present in a mL. 
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Effects of vaccination on disease status in affected cattle 
Emergency vaccination: 
Emergency vaccination can be used in two different ways during an outbreak:  Suppressive 
vaccination is used “to reduce the potential FMDv production in herds that may already have 
been exposed to infection, but in which very few animals are incubating disease”.  Protective 
vaccination is typically used for herds that “are in the vicinity of an outbreak but are thought 
not to have been exposed to live virus” (Kahn et al., 2002).  In both situations, the animals that 
are being vaccinated are those which have not shown clinical signs of infection.  Early induction 
of protective immunity and the use of a broad antigenic spectrum are the two most important 
properties of an emergency FMD vaccine (Cox, Barnett, Dani, & Salt, 1999).  Studies show that if 
animals are sufficiently and adequately immunized by vaccination, within-herd transmission will 
decrease which, in turn, will decrease the likelihood of between-herd transmission (Orsel, de 
Jong, Bouma, Stegeman, & Dekker, 2007; Orsel & Bouma, 2009; Paton, Fussel, Vosloo, Dekker, 
& De Clercq, 2014).  Emergency vaccination with high-potency vaccines against foot-and-mouth 
disease has been shown to be highly effective in preventing clinical signs in animals when the 
correct type and strain are used in the vaccines and when it was administered no less than 4 
days prior to challenge (Barnett & Carabin, 2002; Cox et al., 2005; Doel, Williams, & Barnett, 
1994; Porphyre, Auty, Tildesley, Gunn, & Woolhouse, 2013).  
 
Effects of vaccination on cattle prior to or after exposure to FMDv: 
Studies show that live virus cannot be readily isolated from animals that have undergone 
emergency vaccination and because of this, the likelihood of transmission to susceptible 
animals is low (Cox et al., 2005).  While vaccinated animals appear to be protected from clinical 
infection, sub-clinical infection may still be present, but the level of viral replication in these 
animals has been shown to be “greatly reduced” (Cox et al., 2005; Cox et al., 2007)().  It is 
important, for the purpose of this document, to note that vaccinated animals have been shown 
to become sub-clinically infected if exposed to a sufficient viral challenge and also that 
vaccinated ruminants have been shown to develop the FMD carrier state (Barnett & Carabin, 
2002; Cox et al., 2006; Paton et al., 2014).  The “time of challenge (exposure to the virus) after 
vaccination significantly influences the number of vaccinated animals becoming clinically 
infected” (Cox et al., 2007).  Meaning, a longer period of time between vaccination and virus 
challenge would likely result in fewer animals showing clinical signs.  Most experimental studies 
focus on cattle that had been vaccinated at least three days prior to challenge with FMDv (Cox 
& Barnett, 2009).  This is in contrast to the scenarios in this document that propose vaccination 
of infected herds where animals in all stages of the disease would be immunized.  This also 
emphasizes the importance of vaccinating susceptible premises within the control zone prior to 
moving animals off of infected premises.  Identifying the effects of vaccines on the immune 
responses of actively infected animals should be an area of future research.   
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Effects of vaccination on viral shedding: 
Virus shedding has been shown to be substantially reduced by vaccination with a high-potency 
vaccine (Bates et al., 2003; Cox et al., 1999; Doel et al., 1994; Salt, Barnett, Dani, & Williams, 
1998).  Viral RNA has also been found to be, on average, 100 to 1000 times lower (two to three 
log reduction) in the positive samples of vaccinated animals compared with the unvaccinated 
animals, suggesting vaccination can help reduce the amount of viral shedding into the 
environment shortly after direct challenge (Cox et al., 2005).  Other findings suggest that 
vaccination helps to significantly reduce clinical signs in cattle and prevent viremia (Cox et al., 
2005; Cox et al., 2007; McVicar & Sutmoller, 1976).  Identifying the effects of vaccines on viral 
shedding in animals that had been exposed to the virus prior to inoculation should be an area 
for further research. 
 
Effects of vaccination in carrier cattle: 
Cox, et al., 2005 showed that 45% of vaccinated cattle can become persistently infected where 
much of this virus persists within the oropharynx and/or pharyngeal fluid (Garland ARM., 1974).  
A study by Parida, 2009 states that up to 50% of ruminants can become persistently infected 
regardless of their vaccination status.  However, Doel and Barnett, 1994 showed that there may 
be a correlation between viral persistence and the time lapse between vaccination and 
challenge (Doel et al., 1994).  Viral persistence may also be influenced by the intensity of the 
challenge, as well as the type of vaccine itself (Doel et al., 1994).  
 
A recently published study by Parthiban., et al, 2015 showed that unvaccinated cattle “excrete 
significantly higher levels of virus for longer periods of time compared with vaccinated cattle”, 
which could affect the amount of virus found in the environment at the infected or recovered 
premises (See Table 4).  The environmental viral load may also depend on how many animals 
were able to develop adequate immunity prior to virus exposure.   
 
Table 4:  Number of days in which virus is detected in the secretions of vaccinated and non-
vaccinated carrier cattle (Parthiban, et al., 2015) 
 Carriers 
(unvaccinated) 
Carriers 
(vaccinated) 
Non-carriers 
(unvaccinated) 
Non-carriers 
(vaccinated) 
Units 
Nasal fluid 10 4.5 14 2.5 days 
Saliva 10 2.3 10 2.5 days 
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Modeling Overview 
A stochastic disease transmission model was applied to simulate the spread of FMDv within a 
herd and estimate the number of cattle in various disease states at each time period.  The 
disease states include: susceptible (S), preclinically infectious (Ip), clinically infectious (IC), 
carriers (C) and fully recovered (R).  The main output of the model was to estimate the 
proportion of cattle in different phases of infection at different points in time for the purpose of 
identifying the periods of time that would present the highest likelihood of virus transmission 
when shipping cattle to slaughter. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2:  Model of progression of FMD through an infected feedlot 
 
The model updates the number of cattle in each disease state every day, which provides insight 
into the disease progression through the herd.  The uncertainties in input variables as well as 
the inherent variability associated with the course of infection in each animal and the spread 
within the group are considered in the model. 
 
Parameter distributions for the disease spread model were obtained from previous work by 
APHIS (USDA, 2012). 
 
Table 5:  Input parameters and distributions used in the FMD within-herd model in a beef 
cattle herd 
 
Variable Input Distribution/Value 
Latent Period (1/ λ1) Exponential (0.709) 
Pre-clinical Period (1/ λ2) Log normal (0.862, 0.774) 
Clinical Period (1/ ɣ) Gamma (4.752, 0.736) 
S = Susceptible 
L = Latent 
Ip = Pre-clinical 
Ic = Clinical 
C = Carriers 
R = Fully 
recovered 
*Dotted lines 
were not 
modeled 
1/Tau 
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Carrier Period (1/Tau) Normal (1095, 180) 
q 0.5 
Farm Size 10,000 (beef) 
Adequate Exposures per 
time step 
Poisson (1.5) 
 
The assumptions applied to the model included the following: 
● Transmission occurs 
● Pre-clinically and clinically infectious animals are equally infective with respect to 
transmitting FMD. 
● Cows in the susceptible state in a given time period all have an identical probability of 
becoming infected in the next period (i.e. differences in exposure due to grouping of 
cows in pens is not considered).  This may overestimate the number of adequate 
exposures in large feedlots. 
● Variability in adequate contact due to differences in cow density (number of cows per 
unit area) is not considered (i.e. transmission is modeled as frequency dependent). 
● The probability that a susceptible cow has an adequate exposure with at least one 
infected cow during a time step is, 
𝑃𝑃𝑡𝑡 = 1 − 𝑒𝑒−𝑘𝑘∗𝑁𝑁𝐼𝐼,𝑡𝑡𝑁𝑁−1  
 
Where k is the number of adequate exposures per infected animal, NI,t is the number of 
infectious animals at time t, and N is the total population size.  This equation assumes that 
the number of adequate contacts each cow has in a time period is Poisson distributed with 
mean k.  The number of susceptible animals that become infected with FMD during each 
time step is, 
𝐼𝐼𝑡𝑡,𝑡𝑡+1𝑛𝑛𝑛𝑛𝑛𝑛 ~𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵(𝑆𝑆,𝑃𝑃𝑡𝑡) 
 
● Inputs for the analysis are based on published literature and the best current knowledge 
of the disease biology. 
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Pathway Analysis 
This document is aimed at identifying the main pathways for FMDv spread into susceptible 
species during the movement of cattle not showing clinical signs from an infected premise.  This 
document does not, however, provide an analysis that determines the amount of risk, and 
further research in this area is recommended. 
 
In Figure 3, the main release and exposure pathways are identified as follows: 
 
● Pathway 1:  Cross-contamination with FMDv during movement due to release of 
excretions and secretions from viremic non-clinical cattle, and environmental fomites 
(dirt, bedding, manure, urine) on cattle being moved. 
● Pathway 2:  Aerosol transmission of FMDv particles from latent, viremic non-clinical, and 
recovered cattle during transport. 
● Pathway 3:  Cross-contamination FMDv during movement due to environmental 
contamination on the method of conveyance.   
● Pathway 4:  Aerosol transmission of FMDv particles during transport due to 
environmental contamination on the method of conveyance.   
 
The purpose of this analysis is to identify the different pathways for disease spread, and the 
effects of vaccination status and timelines.  This initial analysis addresses the potential viral 
pathways associated with moving latent, viremic non-clinical, and recovered cattle from a FMD 
infected or recovered premises.  The likelihood of virus spread will vary depending on the 
disease phase in which the animal is in and the scenario that is presented.  
 
Vaccination status may have an effect on the likelihood of disease spread, and these potential 
differences will be addressed in the pathways.  Emergency vaccination of cattle has been shown 
to be effective in preventing or reducing clinical disease and intra-herd transmission and 
decreasing FMDv shedding.  However, the majority of experimental studies were performed in 
animals that had been vaccinated about 3 days prior to disease exposure or challenge.  The 
scenarios presented in this analysis involve the vaccination of cattle on an infected or recovered 
premise that have already been exposed to the virus.  Based on the current understanding of 
FMD vaccine implementation and efficacy, the same pathways (see Table 6) will still be 
addressed in cattle that have been exposed to FMDv prior to vaccination as in those cattle that 
were never vaccinated.  The effect that vaccination has on cattle that have not been exposed to 
virus is explained below. 
 
Table 6 presents an overview of the pathways evaluated in the present document for the 
movement of unvaccinated and vaccinated cattle to the harvest site. 
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Table 6:  Potential FMDv pathways associated with the transportation of unvaccinated and 
vaccinated latent, viremic non-clinical and recovered cattle from infected or recovered farms 
to slaughter 
  Latent Cattle Viremic non-clinical 
Cattle 
Recovered Cattle 
Animal 
Movement 
Pathway 1 
(Mechanical 
Transmission) 
Skin 
Latent -> Pre-clinical 
Environmental Fomites on 
cattle (dirt, bedding, 
manure, urine)  
Excretions/Secretions/Skin 
Environmental Fomites on 
cattle (dirt, bedding, manure, 
urine) 
Environmental fomites on 
cattle (dirt, bedding, 
manure, urine) 
Pathway 2 
(Aerosol 
Transmission) 
Aerosol from OP area 
Aerosol from skin cells 
Aerosol from fomites on 
cattle 
Aerosol via respiration 
Aerosol from skin cells 
Aerosol from fomites on 
cattle 
Aerosol from OP area 
Aerosol from fomites on 
cattle 
  Conveyance 
Conveyance 
(Truck) 
Movement 
Pathway 3 
(Mechanical 
Transmission) 
Environmental Fomites (dirt, bedding, manure, urine) 
Pathway 4 
(Aerosol 
Transmission) 
Aerosol from fomites on cattle 
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Figure 3:  Pathw
ay analysis for m
oving cattle not show
ing clinical signs to slaughter 
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Pathway 1:  Cross-contamination with FMDv during movement due to release of excretions 
and secretions from viremic non-clinical cattle, and environmental fomites (dirt, bedding, 
manure, urine) on cattle being moved. 
 
Latent cattle:  Cattle that are in the latent period have been exposed to virus but virus is not 
yet detectable in blood.  These animals are generally considered not to be infectious and not 
shedding virus.  With that said, virus has been shown to be present in certain skin cells prior to 
the onset of viremia (the end of the latent period).  This potential pathway, however, has never 
been proven to result in disease transmission during this phase of infection and the likelihood is 
very low.  The pathways associated with moving these cattle would be the following:   
 
Unvaccinated:   
- Mechanical transmission from the shedding of skin cells.  There has been no 
evidence of virus transmission due to this route and the likelihood of this 
happening is very low. 
- The disease status of the cattle moves from the latency phase to the pre-clinical 
phase during transport.  Cattle harvest establishments tends to be concentrated 
around feedlots to allow for easy movement to harvest.  USDA states that, on 
average, cattle are transported 100 miles to harvest (Sheilds & Mathews Jr., 
2003) which is equivalent to only about 2 hours of travel time.  Due to a 
relatively short transportation time, it is not likely that cattle in the latent phase 
would enter the pre-clinical phase during transport and therefore, the associated 
likelihood of disease transmission from these animals is low.  
- Mechanical transmission of virus particles found on the animals.  Virus is known 
to survive for days to months in cold weather.  The amount of virus cattle can 
carry on their hides is unknown and should be an area of further research. 
 
Vaccinated:   
- Mechanical transmission from the shedding of skin cells.  While there hasn’t 
been a study addressing the effects of vaccination on this particular topic, there 
is supporting evidence that an effective vaccine can help reduce virus replication 
which can, in turn, result in decreased viral shedding in cattle.  A transmission 
event is unlikely to occur from this group of animals.   
- The disease status of the cattle moves from the latency phase to the pre-clinical 
phase during transport.  Further research is needed to determine the effects of 
vaccination on the length of the latent period, but the likelihood of disease 
transmission from these animals is likely low. 
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- Mechanical transmission of virus particles found on the animals.  Vaccines have 
been shown to decrease FMD viral replication and shedding, which means that 
vaccinating animals will likely result in less environmental contamination. 
 
Viremic non-clinical cattle:  The term viremic non-clinical cattle refers to those animals which 
are pre-clinical and sub-clinical.  During this phase, the animal is viremic, is shedding virus, but 
has either not yet developed clinical signs (pre-clinical) or won’t ever develop clinical signs (sub-
clinical).  These animals represent the highest likelihood of virus spread because they are 
actively infectious and can easily go undetected.  A study conducted by Rueda, et al., 2014 
predicted virus levels to be lower in most secretions from viremic non-clinical cattle when 
compared with clinical cattle.  However, it is still known that disease can occur in this group of 
animals.  Therefore, viremic non-clinical cattle should be treated as if they are secreting a 
similar amount of virus as clinical cattle, out of an abundance of caution, until further research 
into this area is done.  The pathways associated with moving these cattle would be the 
following: 
 
Unvaccinated:   
- Mechanical transmission from infected excretions/secretions.  As stated earlier, 
cattle that are not showing clinical signs can still shed FMDv.  See Table 2 for the 
predicted virus levels in various bodily fluids.  Shedding in viremic non-clinical 
animals represents an area where further research can be done. 
- Mechanical transmission of virus particles found on the animals. 
 
Vaccinated:   
- Mechanical transmission from excrertions/secretions.  Studies show that FMD 
vaccines are unable to protect against sub-clinical infection but they may result 
in decreased viral replication and excretion.  Animals that have had time to 
develop protection following vaccination will shed lower amounts of FMDv and, 
thus, the event of mechanical transmission from animal secretions will be 
unlikely.  Further research is needed to determine the effect of vaccines on virus 
shedding in animals that were exposed to the disease prior to vaccination.  
- Mechanical transmission of virus particles found on the animals. 
 
Recovered cattle:  This term refers to cattle that have recovered from clinical disease.  These 
animals can be split into two groups:  a) Carriers; b) Non-carriers.  Non-carriers are no longer 
carrying the virus and are considered to be noninfectious.  However, it has been shown that 
over 50% of cattle can become carriers.  Carrier cattle have only been shown to harbor virus in 
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the oropharyngeal region and research has not demonstrated that carrier cattle are capable of 
infecting susceptible animals.   
 
Unvaccinated:   
- Mechanical transmission of virus particles found on the animals. 
 
Vaccinated:   
- Mechanical transmission of virus particles found on the animals.  A longer period of time 
between immunization and virus challenge, results in better protection and a decreased 
likelihood of becoming persistently infected.  It is also important to note that vaccinated 
cattle have been shown to carry less virus for shorter periods of time than unvaccinated 
cattle (see Table 4).  Recovered cattle pose a lower likelihood of virus transmission than 
viremic non-clinical cattle and may pose a lower likelihood of virus transmission than 
non-vaccinated carrier cattle. 
 
Pathway 2:  Aerosol transmission of FMDv particles from latent, viremic non-clinical, and 
recovered cattle during transport. 
 
FMDv has generally been shown to be aerosolized through the respiratory route (exhalation).  
In cattle, the average amount of virus excreted via the respiratory route has been reported as 
4.33 log TCID50/mL.   
 
Concern surrounding aerosolization of environmental fomites applies to all latent, viremic non-
clinical, and recovered animals that are being moved from infected and recovered premises as 
FMDv contaminated fecal material can be adhered to the external body surface of the animal.  
Aerosolization and air movement of aerosolized particles is a rare event that requires adequate 
particle size and climatological conditions.  More research is needed to determine how much 
risk is associated with virus becoming aerosolized from the environment. 
 
Latent cattle:  Animals are not viremic in this phase.  However, infectious virus has been found 
to be present in the oropharyngeal area as early as 2-14 hours after intranasal inoculation and 
in the interdigital clefts and coronary bands as early as 6 hours after aerosol exposure to FMDv.  
While the virus has been detected early on, there must be enough virus particles released in 
order for disease to occur.  Therefore, the event of disease spread is very unlikely due to the 
small quantity of virus intermittently found in this phase.  The pathways associated with moving 
these cattle would be the following: 
 
Unvaccinated: 
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- Aerosolization of virus particles from the oropharyngeal area.  This should be an 
area for further study.   
- Aerosolization of infected skin cells.  This should be an area for further study. 
- Aerosol transmission of virus particles found on the animals. 
 
Vaccinated: 
- Aerosolization of virus particles from the oropharyngeal area.  Virus has been 
shown to be present in the OP region prior to the onset of viremia (the end of 
the latent period).  However, this potential pathway has never been proven to 
result in infection during this disease phase and disease transmission unlikely.  
The effects of vaccination on FMDv located in the OP region prior to viremia 
should be an area for further study. 
- Aerosol transmission of virus particles found on the animals.  The amount of 
virus in the environment may be less in a herd that was vaccinated as opposed to 
an unvaccinated herd.  Therefore, the pathway will still be present, but it may be 
less likely for disease transmission to occur via this route.  Further research into 
the amount of virus present in the environment of a vaccinated herd is needed. 
 
Viremic non-clinical cattle:  Viremic non-clinical cattle should be treated as if they are secreting 
the same amount of virus as clinical cattle out of an abundance of caution, pending results of 
further research.  The pathways associated with moving these cattle would be the following: 
 
Unvaccinated: 
- Aerosolization of virus particles from the oropharyngeal area. 
- Aerosolization of infected skin cells.  A less common route of potential aerosol 
transmission was proposed in a review by Dillon, 2011.  This review discusses the 
possibility that exfoliated skin cells may also spread disease through 
aerosolization.  Even though the likelihood may be small, the possibility for 
spread via this pathway must be acknowledged.  This group of cattle will pose a 
higher likelihood of disease transmission due to their ability to shed virus while 
going undetected.   
- Aerosol transmission of virus particles found on the animals. 
Vaccinated: 
- Aerosolization of virus particles from the oropharyngeal area.  Vaccination has 
generally been shown to decrease the amount of virus that is shed.  However, 
even with vaccination, virus has been shown to persist in the pharynx of 
inoculated cattle and, thus, there is potential for aerosolization.  The likelihood 
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of disease transmission from these animals, however, may be lower than viremic 
non-clinical cattle that have not been vaccinated.  
- Aerosolization of infected skin cells. 
- Aerosol transmission of virus particles found on the animals. 
 
Recovered cattle: 
 
Unvaccinated:  The pathways associated with moving these cattle would be: 
- Aerosolization of virus particles from the oropharyngeal area.  Virus has been 
shown to persist in the oro-pharynx of carriers for up to three years and it has 
been shown that disruption (damage) of the cells is often required in order to 
detect virus.  It is, however, highly unlikely the virus can escape and be 
aerosolized.     
- Aerosol transmission of virus particles found on the animals. 
 
Vaccinated:   
- Aerosol transmission from the oropharynx.  While vaccination has been shown 
to decrease the amount of virus shed by cattle clinically affected by FMDv, it has 
not been shown to prevent cattle from entering the carrier state.  While there is 
potential for vaccinated carrier cattle to transmit disease, it is unlikely that this 
event will occur. 
- Aerosol transmission of virus particles found on the animals. 
 
Pathway 3:  Cross-contamination of FMDv during movement due to environmental 
contamination on the method of conveyance.   
 
For the purpose of this analysis, all trailers are assumed to be cleaned and disinfected after 
each load and unload.  This minimizes the amount of fecal material attached to the surface of 
the trailer.  Pathways associated with the movement of a truck and trailer would be: 
 
Unvaccinated:  
-  Mechanical transmission from dirt, bedding and manure that accumulates 
outside and inside the vehicle at the infected or recovered premises during 
loading of animals.  For example, high amounts of FMDv can be shed in feces of 
viremic non-clinical and clinical animals (see Table 2) and also survive in these 
matrices for a long time.  It is, however, unknown the amount of FMDv that can 
accumulate on and within these methods of conveyance and this requires 
further research. 
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Vaccinated:   
- Mechanical transmission from dirt, bedding, manure that accumulated on or 
within the vehicle at the infected or recovered premises during loading.  While 
the pathway is still present, transmission may be less likely to occur in vaccinated 
animals due to decreased shedding of virus in the environment.  However, this 
should be an area for further research. 
 
Pathway 4:  Aerosol transmission of FMDv particles during transport due to environmental 
contamination on the method of conveyance.   
 
Pathways associated with the movement of a truck and trailer would be: 
 
Unvaccinated:   
- Aerosol transmission of virus particles that have been stirred up from the 
environment.  High amounts of virus can be found in fecal material and other 
animal excretions.  Also, the conditions for virus aerosolization are very specific.  
This event seems to be unlikely to occur.  However, more research is needed to 
determine the risk factors that allow the virus to be aerosolized when attached 
to the surface of the trailer. 
Vaccinated: 
- Aerosol transmission of virus particles that have been stirred up from the 
environment.  Vaccinated animals have been shown to shed less virus, and this 
may result in less virus load in the environment.  More research is needed to 
determine if there is a difference in virus levels in these environments and how 
much risk is associated with aerosolized virus from the environment these 
animals live in. 
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Application of the within herd model to specific scenarios 
Five different scenarios were chosen as plausible to occur during a FMD outbreak. In order to 
estimate the number of cattle in each of the disease phases, a within herd disease spread 
model was developed and applied to the scenarios.  This model used a 10,000 head beef cattle 
herd to determine the number of cattle in the latent, pre-clinical, clinical, and recovered phases 
at different times over a time period of 65 days.  This time period was chosen based on how 
long the model predicted it would take for a 10,000 head cattle herd to recover from clinical 
disease.  
 
Scenario 1:  The disease is allowed to progress through an infected herd and at least 42 days 
have passed since the first observable clinical signs prior to movement of eligible cattle (at or 
near target weights) to harvest. 
 
Post-infection:  Literature shows that cattle will recover from clinical infection after 28 days.  At 
this point, cattle enter the recovered phase, which consists of a population of carriers and non-
carriers.  Table 7a reflects the spread of disease through a large herd and displays the number 
of cattle in each disease phase 28 days after the first animal in a 10,000 head beef cattle herd 
was infected (Day 0 = first day of infection in a herd).  
 
Table 7a:  Average number of cattle out of a 10,000 head herd at each disease phase 28 days 
post-infection 
Disease phase Mean 95% Confidence interval 
Susceptible 517 396-638 
Latent 123 102-144 
Pre-clinically infectious 512 470-554 
Clinically infectious 2,851 2,783-2,918 
Recovered 3,010 2,943-3,077 
Carrier 2,988 2,922-3,054 
 
The results of the model used in this document show that at 28 days post-infection in a 10,000 
head herd, 60% of the population (5,998/10,000) will have recovered from the clinical phase of 
FMD, while approximately 34% (3,363/10,000) will still be shedding virus with 15% (512/3,363) 
of these infectious animals going undetected due to pre-clinical infection.  If a decision is made 
to move animals not showing clinical signs at this point, a significant proportion of pre-clinical 
animals (shedding the virus) is predicted to be part of the group moving to harvest. 
 
The time period for moving cattle from the premises to harvest is usually short (a matter of 
hours).  However, there is the possibility that certain animals break with clinical signs before 
the ante-mortem inspection and the whole group be rejected from being harvested.  Also, the 
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viral load in the environment (fecal shedding and airborne transmission) would still be high, as a 
significant proportion of animals are actively shedding virus.  In addition, knowledge of the time 
of infection in any herd is almost impossible due to lack of FMD testing protocols, the latent 
period, and the ability of the disease to remain sub-clinical for a short period of time.  
Therefore, a more practical approach is to establish a timeline of disease spread based on the 
first observed clinical signs in a herd. 
 
Post-detection:   
Scenario 1 refers to a 42 day post-detection waiting period.  This number provided an estimate 
for the amount of time it would take an individual animal to recover.  Therefore, the model was 
run to provide a more accurate prediction of the time it would take an entire herd to recover.  
 
In a large cattle herd, it is assumed that approximately 10% (1,000 cattle in a 10,000 head herd) 
of the herd needs to be showing clinical signs before the disease is detected (Bjork et al., 2013).  
The model used in this document predicted that the time it would take for FMDv to be 
detected would be approximately 17.5 days (95% CI = 17.4-17.7) post infection.  The model 
results show that 96% (9,628/10,000) of a beef cattle herd of 10,000 head will have entered the 
recovered phase at 65.7 days post-infection (95% CI = 65.3-65.9) resulting in a viremic 
population of .009% (.942/10,000).  This means the likelihood of disease transmission would be 
greatly reduced given a 48 day waiting period from the time of detection.  Scenario 1 estimates 
recovery for an individual animal at 42 days.  The model results show that waiting an additional 
6 days for a large herd would result in a lower likelihood of disease transmission from infected 
animals (Table 7b). 
 
  Table 7b:  Average number of cattle out of a 10,000 head herd at each disease phase with 
waiting periods of 42 days (59 days post-infection) and 48 days post-detection (65 days post-
infection) 
 Mean (95% Confidence Interval) 
Disease phase 42 days 48 days 
Susceptible 372(255-489) 372(255-489) 
Latent 0.19(0.12-0.26) 0 
Pre-clinically 
infectious 
1.17(0.68-1.65) 0.002(-.0008-0.005) 
Clinically infectious 188(177-199) 0.94(0.86-1.02) 
Recovered 4784(4725-4843) 4,980(4,919-5,040) 
Carrier 4654(4598-4711) 4,648(4,778-4,835) 
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The model predicts that approximately 46% (4,980/10,000) of recovered cattle will become 
carriers and FMDv may persist in the pharynx at the time of transportation and the remainder 
of the cattle will fully recover with no virus persistence. 
 
Potential Pathways: 
Table 7c lists the potential disease pathways that are associated with this scenario.  The main 
pathways would be mechanical transmission of virus from a recovered feedlot and the 
possibility of aerosol spread of virus from carrier cattle.  As stated earlier, there is no evidence 
to support that carrier cattle are capable of transmitting FMDv to susceptible animals which 
would indicate that transmission from these animals is not likely.  The possibility of virus 
traveling via environmental fomites from cattle hides or the method of conveyance is possible, 
but further research needs to be done in this area to quantify the associated risk. 
 
Table 7c:  Scenario 1 potential FMDv pathways         
Pathway 
Animal 
Movement 
PW1 
(Mechanical) 
Environmental contamination on animals 
PW2 
(Aerosol) 
Carrier:  Virus from OP area 
Environmental contamination on animals 
Conveyance 
(Truck) 
Movement 
PW3 
(Mechanical) 
Environmental contamination on the truck 
PW4 
(Aerosol) 
Environmental contamination on the truck  
 
Scenario 2:  The feedlot is actively infected (animals with clinical signs are present) and cattle 
not showing clinical signs of FMD (non-infected, latent, viremic non-clinical, recovered) that 
are eligible for harvest (at or near target weights) are moved to harvest. 
 
While latent and carrier cattle are not known to present a risk for transmission of FMDv, 
viremic non-clinical (pre-clinical and sub-clinical) animals are known to be a source of virus 
transmission to susceptible animals.  Depending on where the transportation date falls in the 
progression of the disease through the feedlot, there could be a higher or lower likelihood of 
disease transmission associated with the movement of the animals (see Table 8a).  In addition, 
a feedlot that is currently infected is likely to contain more virus in the environment, compared 
to a recovered feedlot, due to the presence of viremic animals that are actively shedding virus.  
For these reasons, transporting cattle in Scenario 2 will result in a higher likelihood of 
transmitting FMDv to susceptible animals than transporting cattle in Scenario 1 (unvaccinated 
cattle - waiting period of 42 days post-detection).  Table 8c lists the potential pathways that are 
associated with each pathway in this scenario.   
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Table 8a:  Average number of cattle out of a 10,000 head herd at each disease phase at 0, 11, 
18, 25, 32, and 29 days post-detection 
 Mean (95% CI) 
Disease Phase 0 days 11 days 18 days 25 days 32 days 39 days 
Susceptible 6,620(6,547-
6,694) 
517(396-638) 377(260-494) 372(255-489) 372(255-489) 372(255-489) 
Latent 1,376(1,319-
1,432) 
123(102-144) 6.3(2.4-10.2) 0.2(0.1-0.3) 0.03(0.02-
0.05) 
0.006(0.0005-
0.01) 
Pre-clinically 
infectious 
1,095(1,064-
1,125) 
512(470-554) 31(22-39) 1.2(0.7-1.6) 0.1(0.06-0.2) 0.02(0.01-
0.03) 
Clinically-
infectious 
692(682-702) 2,851(2,783-
2,918) 
861(823-900) 188(177-199) 38(36-41) 7.6(7.1-8.1) 
Recovered 108(106-111) 3,010(2,943-
3,077) 
4,397(4,339-
4,456) 
4,784(4,725-
4,843) 
4,891(4,831-
4,950) 
4,937(4,876-
4,997) 
Carrier 108(106-111) 2,988(2,922-
3,054) 
4,328(4,271-
4,385) 
4,654(4,598-
4,711) 
4,699(4,642-
4,757) 
4,684(4,627-
4,741) 
 
Assuming FMD would be detected at approximately day 17 (Day 0 = day of first infection in 
herd), a waiting period of 25 days post-detection would result in a reduced likelihood of disease 
transmission.  At this point, approximately .012% (1.2/10,000) of pre-clinical cattle are 
predicted to be present in the herd and there would be a lower likelihood of moving viremic 
cattle.  Not all cattle will be moved at once, so as the waiting time progresses past the 25 days, 
the likelihood of transporting a pre-clinical animal decreases, as can be seen in the above table.  
This number, however, does not include the number of sub-clinical cattle that may be present 
in the herd and shedding a similar amount of FMDv as clinical cattle.  Literature has shown 
approximately 11% of cattle may remain sub-clinical (Henderson WM., 1985; Sutmoller and 
Olascoaga, 2002).  The model used in this document did not account for sub-clinical cattle and 
this could be an area for future research.   
 
Table 8b:  Scenario 2 potential FMDv pathways 
Pathway 
Animal 
Movement 
PW1 
(Mechanical) 
Latent:  Skin, transition to pre-clinical 
Viremic non-clinical:  Excretions/secretions/skin 
Environmental contamination on animals 
PW2 
(Aerosol) 
Latent: Virus from OP area, skin 
Viremic non-clinical: Skin/respiration 
Carrier:  Virus from OP area 
Environmental contamination from the animal 
Conveyance 
(Truck) 
Movement 
PW3 
(Mechanical) 
Environmental contamination on the truck 
PW4 Environmental contamination on the truck 
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(Aerosol) 
 
Scenario 3:  Upon detection, all cattle in the infected feedlot are vaccinated, at least 42 days 
have passed since the first observable clinical signs in the herd and cattle eligible for harvest 
(at or near target weights) are subsequently moved to harvest.  
 
This scenario addresses the pathways associated with transportation of vaccinated carriers.  
Cattle that were vaccinated prior to exposure have been shown to remain carriers for a shorter 
period of time and harbor significantly less virus than cattle that were not vaccinated (Parthiban 
ABR., et al., 2015).  It is unknown whether this applies to animals that were vaccinated after 
exposure to the virus.  In this scenario, many of the animals will be vaccinated after exposure 
which means that there may be more viral shedding and more carriers present than if the 
animals had been vaccinated prior to exposure.   
  
Scenario 3 is similar to Scenario 1 (unvaccinated cattle - waiting period of 42 days post-
detection) in that animals will not be moved until the whole herd is assumed to have reached 
the “recovered” state.  As stated above, the time at which 96% of a  10,000 head beef cattle 
herd was predicted to be in the recovered phase was approximately 65.7 (95% CI = 65.2-66.1) 
days post-infection, which means a 48 day waiting period from the time of detection would 
result in a lower likelihood of moving viremic cattle (Tables 7b).  In summary, Scenario 3 results 
in less likelihood of disease transmission than Scenario 2 (unvaccinated cattle moved prior to 
herd reaching recovered phase) and a similar or lower likelihood of disease transmission than 
Scenario 1.  The variability in the likelihood of disease transmission in comparison to Scenario 1 
exists because of the possibility of lower levels of virus in the environment due to an assumed 
decrease in viral shedding from vaccinated animals.  The identified pathways in this scenario 
are presented in table 9.     
 
Table 9:  Scenario 3 potential FMDv pathways 
Pathway 
Animal 
Movement 
PW1 
(Mechanical) 
Environmental contamination on animals 
PW2 
(Aerosol) 
Carrier:  virus from OP area 
Environmental contamination from the animal 
Conveyance 
(Truck) 
Movement 
PW3 
(Mechanical) 
Environmental contamination on the truck 
PW4 
(Aerosol) 
Environmental contamination on the truck 
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Scenario 4:  Upon detection, all cattle in the infected feedlot are vaccinated, at least 14 days 
have passed as the waiting period and cattle not showing clinical signs of FMD (non-infected, 
latent, viremic non-clinical, recovered) that are eligible for harvest (at or near target weights) 
are moved to harvest. 
 
Cattle that have been vaccinated have been shown to have less severe or no clinical signs, and 
decreased shedding.  There may also be some evidence to indicate fewer of these animals 
become sub-clinically infected.  However, much of this research has been applied to animals 
that were vaccinated prior to exposure or challenge and it is important to consider the same 
pathways that were identified for unvaccinated animals leaving an infected or recovered 
premise because of this unknown.  Based on current literature, the number of cattle in each 
disease phase at these time periods would be very similar to those in Scenario 2 (unvaccinated 
cattle moved prior to herd reaching recovered phase) (See Table 8a).  An exception to this 
might be the number of cattle that are in the clinical phase as vaccination has been shown to 
prevent development of clinical disease (this is not addressed in the model that was developed 
for this report).  However, this scenario is different in that vaccination is being applied to all 
cattle in an infected herd, leaving little to no time for immunity to develop.  This brings to 
question whether a larger proportion of cattle will develop clinical signs than what has been 
published in literature and could be an area for further research.  However, a decrease in viral 
shedding from this herd may still result in a lower likelihood of disease transmission. 
 
If FMDv was detected on day 17 and cattle were immediately vaccinated, this scenario would 
mean movement of these animals no sooner than 31 days after initial infection with the 14 day 
waiting period.  Table 10a shows that on day 31, approximately 0.34% (34/10,000) of the herd 
will be in the latent phase, and approximately 1.59% (159/10,000) of the herd will be in the pre-
clinically infectious phase.  Should a decision be made to move the eligible cattle as stated in 
this scenario, a higher likelihood of disease transmission would be present than in Scenarios 1 
(unvaccinated cattle – waiting period of 42 days post-detection) and 3 (vaccinated cattle – 
waiting period of 42 days post-detection) where there would be smaller chance of moving pre-
clinical cattle (See Table 8a).   
 
Table 10a:  Number of cattle in each disease phase out of a 10,000 head herd at 14 days post-
detection 
Disease Phase Mean (95% CI) 
Susceptible 317(214-420) 
Latent 34(22-46) 
Pre-clinically infectious 159(138-179) 
Clinically-infectious 1862(1802-1922) 
Recovered 3836(3779-3894) 
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Carrier 3792(3735-3849) 
 
As in other scenarios, the timeline is important and implementation of a vaccination program at 
various points in the timeline will yield results that could result in different likelihoods of 
disease transmission.  This scenario will result in a higher likelihood of disease transmission 
than Scenarios 1 and 3 and a similar to or lower likelihood than that of Scenario 2.  The 
additional time that is given for the animals to recover in Scenarios 1 and 3 offers an additional 
layer of protection.  This is because studies show virus to only persist in the oropharyngeal area 
of cattle after 28 days have passed since the last observable clinical signs.  In comparison to 
Scenario 2, assumptions can only be made as to the effects of the vaccine on animals in an 
actively infected herd, which could result in fewer clinical cattle and a lower amount of viral 
shedding.  Further research is recommended to quantify whether there is a significant 
difference in risk between vaccinated and non-vaccinated cattle in an actively infected herd. 
 
Table 10b:  Scenario 4 potential FMDv pathways 
Pathway 
Animal 
Movement 
PW1 
(Mechanical) 
Latent:  Skin, transition to pre-clinical 
Viremic non-clinical:  Excretions/secretions/skin 
Environmental contamination on animals 
PW2 
(Aerosol) 
Latent:  Skin, OP area 
Viremic non-clinical:  Skin, respiration 
Carrier:  Virus from OP area 
Environmental contamination from the animal 
Conveyance 
(Truck) 
Movement 
PW3 
(Mechanical) 
Environmental contamination on the truck 
PW4 
(Aerosol) 
Environmental contamination on the truck 
 
Scenario 5:  The feedlot is not known to be infected (infected but undetected or negative) and 
located within a control zone.  All animals have been vaccinated and cattle eligible for harvest 
(at or near target weights) are moved to harvest after the 14 day waiting period. 
 
The main pathways associated with this scenario would be the movement of viremic non-
clinical cattle from an infected but undetected premise.  As stated above, if the disease is 
present and not detected until 10% (Day 17) of the herd is affected, FMDv will most likely not 
be detected in this herd prior to transport, resulting in the movement of infectious animals.  
Infection can occur any time before or after vaccination.  One scenario might assume the initial 
infection occurred less than 17 days prior to the date of movement, and therefore go 
undetected.  For example, should a decision be made to move animals 14 days after the herd 
was infected, there is a higher likelihood of transporting a large number of viremic pre-clinical 
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animals as approximately 3% (343/10,000) of the herd would fall in this category. Table 11a 
summarizes the number of animals that can be expected to be in each phase during day 14.  
 
If the herd remains uninfected, there would be no risk to nearby susceptible premises during 
movement of these cattle.   
 
Table 11a:  Number of cattle in each disease phase out of a 10,000 head herd at 14 days post-
infection 
Disease Phase Mean (95% CI) 
Susceptible 8,954(8,886-9,022) 
Latent 438(404-471) 
Pre-clinically infectious 343(318-368) 
Clinically-infectious 204(190-219) 
Recovered 31(29-33) 
Carrier 31(29-33) 
  
An effective FMD vaccine has been shown to confer protection in 4 days.  Had the vaccine been 
administered prior to infection, it is likely that it would take even longer for the operation to 
detect clinical signs because of the ability of the vaccine to prevent clinical signs.  If the herd is 
determined to be infected over the course of those 14 days, a large number of animals will be 
assumed to be viremic non-clinical, but it can also be assumed there will be less virus shedding, 
fewer viremic non-clinical animals, and a larger proportion of cattle with full protection from 
immunization than what is observed in Scenarios 3 (vaccinated cattle – waiting period of 42 
days post-detection) and 4 (vaccinated cattle – waiting period of 14 days post-immunization).  
This is because the vaccine has had more time to provide protective immunity in these animals.  
 
Potential pathways remain the same as those in Scenarios 2 (unvaccinated cattle moved prior 
to herd reaching recovered phase) and 4, with the exception of the presence of carriers.  
However, there could be a lower likelihood of disease transmission associated with cattle 
movement in Scenario 5 than in Scenarios 2 and 4 because of the possibility of increased length 
of time between vaccination and exposure to the virus, therefore, providing protective 
immunity and decreasing virus shed. 
 
Table 11b:  Scenario 5 potential FMDv pathways 
Pathway 
Animal 
Movement 
PW1 
(Mechanical) 
Latent:  Skin, transition to pre-clinical 
Viremic non-clinical:  Excretions/secretions/skin 
Environmental contamination on animals 
PW2 Latent: Skin, OP area 
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(Aerosol) Viremic non-clinical:  Respiration, skin cells 
Environmental contamination from the animal 
Conveyance 
(Truck) 
Movement 
PW3 
(Mechanical) 
Environmental contamination on the truck 
PW4 
(Aerosol) 
Environmental contamination on the truck 
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Conclusions 
• Variables that were determined to contribute significantly to disease spread in the 
scenarios presented in this document were:  Mechanism of spread, disease phase, time 
of movement, and vaccination status. 
• Samples from infected animals that were shown to contain the most virus were:  Nasal 
discharge, upper respiratory tract samples, skin, probang samples, airborne excretion. 
• Samples from infected animals that were shown to contain the least amount of virus 
were:  Manure and urine. 
• Viremic non-clinical (pre-clinical and sub-clinical) cattle were determined to present the 
highest likelihood of virus transmission to susceptible premises. 
• Latent and carrier cattle were determined to present the lowest likelihood of virus 
transmission to susceptible premises. 
• The highest proportion of shedding animals 33% (3,363/10,000) was predicted to be 
present around 11 days post-detection. 
• The lowest proportion of shedding animals 0.009% (0.094/10,000) was predicted to be 
at 48 days post-detection.  Therefore, a 48 day waiting period from the time of 
detection would significantly reduce the chances of moving a viremic non-clinical animal 
from a recovered premise. 
• Should the decision be made to move animals from an actively infected premise, a 
waiting period of 25 days post-detection would result in a proportion of 1.89% 
(189/10,000) shedding animals compared to a waiting period of 14 days post-detection 
which would result in a proportion of 20% (2,021/10,000) shedding animals. 
• Vaccinated animals may be less likely to transmit disease compared with non-vaccinated 
animals due to decreased shedding.  However, this may be affected by the time lapse 
between immunization and virus challenge, as well as strength of the virus challenge. 
• Further research is recommended to better estimate the risk of disease spread 
associated with each pathway and to be able to provide recommendations for the 
movement of cattle in these scenarios. 
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Limitations 
- Virus characteristics were described based on the use of experimental work, 
which used a limited numbers of animals and specific virus strains. 
- The scenarios did not account for the time it would take to manufacture, deliver, 
and administer vaccines following detection of a positive herd. 
- The model developed for this report did not include the number of animals that 
would be in the sub-clinical phase at each time step. 
- The model did not account for the differences in virus characteristics. 
- The model did not account for the different feedlot set ups or feedlots of 
different sizes. 
- The model assumed all animals had a chance to come into contact with one 
another and did not account for the possibility of sub-populations within a herd. 
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Recommendations for further research 
1. Identification and quantification of the risk of transmission from a non-
vaccinated infected feedlot to nearby susceptible premises. 
2. Identification and quantification of the risk of transmission from a vaccinated 
infected feedlot to nearby susceptible premises. 
3. Identification and quantification of differences in shedding between animals that 
are pre-clinical and animals that remain sub-clinical instead of entering the clinical state. 
4. Identification and quantification of the potential risk of associated with FMDv 
leaving a facility that slaughters infected animals. 
5. Quantification of the amount of viral shedding via respiratory exhalation of 
carrier cattle. 
6. Assessing the number of cattle that remain sub-clinical in an affected herd. 
7. Assessing the risk for disease transmission due to aerosolization of infected skin 
cells. 
8. Assess the effect of vaccines on virus persistence in the OP region. 
9. Identification of the effect of different weather conditions on the amount of 
infectious virus in the environment of different sized feedlots at various times during 
disease progression. 
10. Quantification of the amount of virus from the environment that can accumulate 
on an animal at various time intervals. 
11. Quantification of the amount of virus from the environment that can accumulate 
on a cleaned and disinfected truck and trailer in the time it enters the infected and/or 
recovered property to the time it leaves. 
12. Quantification of the amount of virus that can be aerosolized from 
environmental contamination on animals and methods of conveyance during transport. 
13. Quantification of the amount of infectious virus present in the OP region and in 
the skin cells of the coronary band of cattle at different disease phases. 
14. Quantification of the amount of virus shed in various secretions/excretions from 
viremic non-clinical cattle. 
15. Quantification of the amount of virus shed in various excretions/secretions of 
vaccinated latent, viremic non-clinical, and clinical cattle. 
16. Effects of a vaccine on animals in various phases of the disease. 
17. Assess the impact of using a non-random within herd spread model. 
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Appendix I:  Overview of US beef production and movement 
US Beef Production 
In 2013, the US ranked as the world’s fourth largest global beef producer with beef exports 
valued at $5.722 billion.  This value increased to $6.520 billion in 2014.  In 2012, it was 
estimated that the number of all US cattle and calf operations was 915,000 and the majority of 
the beef operations (approximately 742,000 in 2010) could be found in Texas, Oklahoma, 
Missouri, Nebraska and South Dakota.  As of July 2015, the total US cattle inventory was 
estimated at a total of 98.4 million head of which approximately 30.5 million are beef cattle.  
The beef industry specifically, consisted of 4.90 million beef replacement heifers, 30.5 million 
beef cows and a calf crop of 34.3 million.  Cattle and calves at feedlots for the slaughter market 
totaled 12.1 million head.  Feedlots with 1,000 or more head accounted for 85% of total cattle 
on feed in July 2015 (FAO, 2015; USDA ERS, 2015; USDA NASS, 2015).  According to USDA NASS, 
742,000 beef operations were recorded to exist in the US in 2010 with approximately 77,140 of 
these being feedlots (see Figure 4).  This number has declined gradually since 1996 at about 1 
to 2% each year.  The decrease, however, has been seen primarily in small operations (1 to 49 
head).  As small operations decrease, large operations (100 or more head) continue to get 
larger.  Today, large feedlots account for over 80% of all cattle that are on feed (See Table 12). 
 
 
Figure 4: Cattle on Feed, 2010 
(SOURCE:  FAD PReP Beef Feedlot Industry Manual 2011, pg. 2 (USDA APHIS, 2011)) 
 
Table 12:  U.S. Cattle Inventory, 2015 ((USDA NASS, 2015)) 
Group No. of Head 
All cattle and calves 98.4 million 
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Beef cows and heifers that calved 30.5 million 
Beef replacement heifers 4.90 million 
Cattle and calves on feed 12.1 million 
 
The US beef industry is divided into two main production sectors and an intermediate sector 
that are distributed throughout the US:  cow-calf operations, backgrounding, and cattle feeding 
(USDA, 2012). 
 
Cow-calf operations:  While these operations are located throughout the US, there are clusters 
in the Southeast US, Southern Plains and Mountain Regions (See Figure 5).  These herds depend 
heavily on range and pasture forage conditions as they live primarily off of forage from the 
pastures with little, if any grain.  The calf is maintained on pasture with the cow until it is 
weaned, at which point it is moved to a feedlot.  The average beef cow herd is 40 head, but 
about 9% of beef operations have 100 or more beef cows.    
 
Backgrounding (Stocking):  Younger or lighter-weight calves may be sent to a backgrounder 
where they are given additional time to gain weight.  This stage begins when a calf is weaned 
and ends when the animal is placed in a feedlot and relies heavily on pasture combined with 
grain to increase the calf’s weight prior to entering a feedlot. 
 
Cattle feedlots:  While many of these operations are located in the Great Plains, they are also 
located in parts of the Corn Belt, Southwest, and Pacific Northwest (See Figure 6).  This data is 
from the most recent census which was in 2002.  The purpose of moving cattle to these 
feedlots is to put them in an environment that is conducive to weight gain.  Feeder cattle are 
typically kept at feedlots for 160 days (Personal communication Robert De Otte Jr.), but this can 
range from 90 to 300 days depending on desired finish, feeding conditions and other variables.  
For the purpose of this analysis, a 10,000 head feedlot is used.  In general, there are six feedlot 
facility types (USDA APHIS, 2011): 
1. Earthen lot with or without mounds 
2. Earthen lot with a windbreak or shed 
3. Earthen lot without a windbreak or shed 
4. Concrete lot with a shed 
5. Complete confinement building with solid floor (concrete or earthen) 
6. Complete confinement building with slotted floor.   
When it comes to land, feedlots should be hard surfaced, but manure and mud in feedlots can 
become a problem when there are lower evaporation rates in the winter and/or improper 
drainage conditions.  If prevention measures are unsuccessful, farmers provide mounds of soil 
and/or additional bedding, such as corn husks or straw to improve conditions (Pohl, 2002).  
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Figure 5:  USDA ERS Farm Production Regions 
(SOURCE:  USDA ERS) 
 
 
Figure 6:  USDA Cattle on Feed 
(SOURCE: (USDA, 2002)) 
Beef Cattle Movement Flows 
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Cattle movements occur throughout the US and the largest volume tends to be into and within 
the Northern and Southern Plains (Sheilds & Mathews Jr., 2003), as can be seen in Figure 7.  It is 
important to note that much of the data on cattle movement is based on Interstate Certificate 
of Veterinary Inspection (ICVI) documentation which is required for the movement of all 
livestock across state lines except for those that are destined for slaughter (USDA APHIS, 2013).   
So, while this information can provide insight into where a large proportion of cattle are located 
and where they move, it doesn’t account for the movements of cattle from feedlots to 
slaughter, which is the focus of this analysis. Shipping distance varies depending on the location 
of the feedlot and where the cattle are marketed. When it comes to moving feedlot cattle to 
slaughter, on average, they are shipped approximately 100 miles.  Cattle slaughter tends to be 
concentrated, with more than two-thirds of the operations occurring in the same states as 
many of the feedlot operations (Sheilds & Mathews Jr., 2003).  
 
Movement Restrictions 
It is important to note that in the event of an FMD outbreak, vaccinated animals without clinical 
signs will not be allowed to move until 14 days post-vaccination  (USDA APHIS, 2014).    
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7:  Region cattle flows as depicted by USDA ERS 
(SOURCE:  (Sheilds & Mathews Jr., 2003)) 
 
 
Beef Cattle Transportation Characteristics 
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The mode of transportation evaluated for the movement of cattle from an FMD-infected 
feedlot to a slaughter establishment is a trailer.  Low stock trailers (goosenecks) are used to 
transport smaller numbers of cattle (Figures 8A and 8B).  Stock trailers range from 16’ ‘to 40’.  A 
semi or “pot” trailer is more commonly used as they are able to transport larger groups of 
cattle over a longer distance (Figures 9A and 9B) (USDA APHIS, 2011).  These trailers can range 
from 34’ to 53’   feet.  Trailers are required to be well-ventilated to protect animals from 
accumulation of exhaust fumes from other vehicles, excessive heat, high humidity and 
accumulation of ammonia from urine (Chambers & Grandin, 2001).  Non-slip floors are 
recommended in all trailers to prevent animals from losing their footing.  This can be done by 
using a cross slating grid made from metal or wood or by putting grass or sawdust on the floor 
of the trailer (Chambers & Grandin, 2001).   While full ventilation is required in warm weather, 
it is recommended to cover one-third to one-half of the holes with plastic panels in a semi-
trailer in cold weather to keep cattle at a comfortable temperature during movement (Grandin, 
2007).     
 
Figure 8A and 8B : Gooseneck low stock trailer            Figures  9A and 9B:  Semi trailer                     
(Exterior and Interior)               (Exterior and Interior)   
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(SOURCES:  8A) Fthr.com; 8B) Swamericana.wordpress.com; 9A and 9B) 
Feedyardfoodie.wordpress.com) 
 
Transporting animals in a humane manner means providing enough space for each animal to 
remain comfortable over a long distance.  Figure 10 provides recommendations for the number 
of cattle to be transported based on cattle weight and stock trailer size.  Large feedlots tend to 
use semi-trailers for transporting cattle to slaughter.  For semi-trailers the FAO recommends 1.0 
to 1.4 m2 of floor area per animal, and limits are based on total weight and the number of axels.  
In the U.S. it is common to ship loads that are approximately 48,000 to 50,000 lbs, which is 
approximately 30 to 42 cattle, with the average typically being 35 or fewer head (Personal 
communication: Timothy Goldsmith, Robert De Otte Jr.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10:  Cattle Transport Guidelines 
(SOURCE:  (USDA APHIS, 2011)) 
 
Transportation Regulations 
Transportation regulations require that cattle are not confined in a vehicle for longer than 28 
consecutive hours unless there are accidental or unavoidable or when the owner has requested 
that the 28 hour period be extended to no more than 36 hours.  If permission for one of these 
exemptions is not granted, cattle are to be unloaded, fed, watered and allowed to rest for no less 
than 5 consecutive hours (U.S. Code 2011, Title 49 Chapter 805, Section 80502). 
 
 
